The use of misoprostol for postpartum haemorrhage among midwives in primary healthcare facilities in Edo state, Nigeria.
Keywords:
factors, treatment, prevention, misoprostol, Post Partum HaemorrhageAbstract
Background: Postpartum haemorrhage is a leading global cause of maternal morbidity and mortality. The use of misoprostol in the prevention and treatment of PPH has been shown to be effective particularly in low resource settings where regular supply and maintenance of efficacy of oxytocin and ergometrine cannot be ensured. This study aimed to determine midwives'knowledge and usage of misoprostol in the management of Postpartum haemorrhage in Edo Central Senatorial District.
Methodology: It was a descriptive cross-sectional survey involving 126 midwives. An all- inclusive sampling was adopted for the study. Data was collected by means of a structured questionnaire. Collected data were analysed and presented by means of frequencies and percentages. Pearson's correlation analysis was used to test the hypotheses.
Results: This study showed that 40.5% and 42.9% of respondents knew the correct dose, 77%and 46.8% knew the correct route and 37.3%and 77.8%knew the correct time of administration for prevention and treatment of PPH respectively. In the prevention of PPH, 42.9%of respondents administer misoprostol at the correct time, 46.8%at the correct dose and 66.7%through the correct route whereas, in the treatment of PPH, 62.7% of respondents administered misoprostol at the correct time, 43.7% at the correct dose and 54% through the correct route. Only 38%of respondents had received training on use of misoprostol for PPH. Factors influencing misoprostol use among the participants were training, adequate knowledge, availability, and effectiveness of misoprostol. There was a significant relationship between midwives' professional qualifications and years of service and correct use of misoprostol.
Conclusion: Theknowledge of misoprostol use was still low, and midwives still used misoprostol incorrectly in the management of PPH. It is recommended that relevant authorities should invest in training and retraining of midwives on use of misoprostol for the management of PPH.
Downloads
References
1. Kinikanwo, I. G., John, D. O. and Mmon, C. F., (2015). Primary Postpartum Haemorrhage at the University of Port Harcourt Teaching Hospital: Prevalence and Risk Factors. The Nigerian Health Journal, Vol.15, No. 3 (111-117).
2.Smith, J. S., (2018). Postpartum Haemorrhage Treatment and Management. Medscape.https//emedicinemedscape.com/article/275038-treatment
3.Uthman, G. S., Kwanashie, H. O., Mairiga, A. G., Gamaniel, K. S., Isa, M. H., Abdu, I. A., Geidam, A. D. and Nwaosu, C. S. (2011). A randomized
clinical trial comparing the efficacy of oxytocin injection and oral misoprostol tablet in the prevention of postpartum hemorrhage in Maiduguri Nigeria. International Research Journal of Pharmacy2 (8): 76-81.
4. WHO, (2012). WHO recommendations for the prevention and treatment of postpartum haemorrhage. Available at: http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf.
5. Ononge, S., Campbell, O. and Mirembe, F. (2015). Effectiveness and Safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-birth: a stepped-wedge cluster randomized trial. Biomedcentral.com (BMC). Pregnancy and Child-birth. Article 315: 50-56.
6. Prata, N. and Weidert, K. (2016). Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973720/#b19-ijwh-8-341
7. Okonofua, F.E., (2010). Knowledge and correct use of misoprostol among primary health workers in Edo state. Retrieved from http://where-online.org/sites/default/files/reports/Edo-Misofinal.report.2010
8. International Confederation of Midwives (ICM) and International Federation of Gynaecology and Obstetrics (FIGO), (2017). Prevention and Treatment of Postpartum Haemorrhage: new world advances for low resource settings. International Journal of Gynaecol Obstetrics.97: 160-3.
9. International Federation of Gynaecology and Obstetrics (FIGO), (2012). Prevention of Postpartum Haemorrhage with isoprostol.Guideline in brief.Available at www.figo.org.
10. Federal Ministry of Health (FMOM), (2011). Clinical guideline on use of misoprostol: an addendum to the National Clinical Service Protocol
for Obstetric Care. Federal Ministry of Health Abuja.
11. Duduyemi, A. O., Okafor, I. P. and Oridota, S. E., (2019). Misoprostol, Magnesium Sulphate and Anti-shock Garment: A Knowledge, Availability and Utilization Study at the Primary Health Care Level in Western Nigeria. Available at https://pubmed.ncbi.nlm.nih.gov/308970
96/
12. Abayomi, S. O., (2017). Assessment of Primary Health Care facilities' readiness in Nigeria. Biomedcentral Health Services Research 17(172) pp2-8. DOI 10-1186/s12913-017-2112-8
13. Baig, M., Jan, R.,Lakhani, A., Ali, S. A., Mubeen, K., Ali, S. S., and Adnan, F.,(2017).Knowledge, Attitude, and Practices of Mid-Level Providers
regarding Post Abortion Care in Sindh,Pakistan .Journal of Asian Midwives4(1): 21–34.
14. Starrs, A. and Winikoff, B. (2012). Misoprostol for Postpartum Haemorrhage: Moving from evidence to Practice. International Journal of Gynaecology and Obstetrics.116: 1-3.
15. Kibusi SM, Mwampagatwa I, Angelina JA. Factors influencing nurses' knowledge and skills in the prevention and management of postpartum haemorrhage. Afr J Midwifery. 2019; 13(4): 1–12. https://doi.org/10.12968/ajmw.2018.0018
Downloads
Published
Issue
Section
License
All articles published in the journal are licensed under a Creative Commons Attribution (CC BY) license(i.e CC Attribution-NonCommercial-ShareAlike 4.0), allowing others to share, distribute, and build upon the work, provided the original author(s) and source are properly cited. Authors retain the copyright of their work.
